The NeuroCatch Platform is a 6-Minute Brain Function Assessment System Licensed by Health Canada as a Class II Medical Device VANCOUVER, British Columbia, July 22, 2021 (GLOBE NEWSWIRE) -- KetamineOne ...

Surrey, B.C. and Calgary, A.B. (August 20, 2019) - NeuroCatch Inc., a brain-focused health technology company committed to translating research innovations into real-world medical devices and ...

BOSTON, April 9, 2024 /PRNewswire/ -- NeuroCatch Inc., a leading medical device company that enables rapid access to an objective assessment of brain health at the point of care, today announced the ...

NeuroCatch Inc., a brain-focused health technology company committed to translating research innovations into real-world medical devices and applications, is pleased to announce a research ...

We’re proud to partner with NeuroCatch to deliver innovative brain health assessment tools to those who have served our country.” — Chris Lovell, CEO of Lovell Government Services PENSACOLA, FL, ...

Groundbreaking collaboration supports cutting-edge research to improve brain health assessment for military service members. Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - NeuroCatch ...

VANCOUVER, BC, Nov. 28, 2024 /PRNewswire/ - NeuroCatch is proud to announce its integration into a new cognitive performance program for elite athletes: Elevate by NeuroCatch. This program is designed ...

Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - NeuroCatch Inc., a leader in objective cognitive brain health assessment, today announced a research partnership with The Geneva ...